Innovative solutions for industry and society with accelerator-based technologies

„The increasing demand for space electronics requires more radiation hardness testing capacity with easy and regular access to irradiation facilities for industrial users. Pooling radiation hardness testing capabilities in Germany under the umbrella of the Hi-Acts initiative as well as improving access schemes is very valuable for the radiation effects community to this end.“

Radiation Effects Physicist at CERN

„Synchrotrons deliver high-throughput measurements that give material R&D a critical edge, allowing complete parameter spaces, like formulations, to be analyzed in one step. BASF has leveraged this with our spin-out, Momentum Transfer, to streamline development and control research costs. Hi-Acts provides invaluable connections and an ideal collaborative environment. Based at DESY since 2024, we benefit from close work with top scientists.“

Chief Scientific Officer at Momentum Transfer/BASF

„For us as a radiopharmaceutical company, the reliable supply of high quality and innovative therapeutic and diagnostic radionuclides is crucial. Locally available, accelerator-based solutions that fit seamlessly into local value chains are central to our business. For this reason, Hi-Acts, as an initiative to facilitate the exchange between industry and academia for accelerator-based technologies, is of significant added value.“

Head of Pharmaceutical Development at ROTOP

„We have to quickly transfer basic research into industrial application in order to meet challenges in supply chains. To do this, we need collaboration between research and industry partners, we need Hi-Acts!“

Managing Director at Cup Contract Labs

„The industrialisation of advanced accelerator technologies, including laser plasma-induced secondary radiation, is extremely complex. One company alone cannot achieve this. A close dialogue with partners in industry is just as important for this as networking with the scientific community. It’s a matter of creating what you might call an innovation ecosystem. That’s what we consider Hi-Acts to be. It’s an investment into the future, and it will pay off in the long term.“

IP Manager Business Division LT at TRUMPF GmbH & Co KG

„Many of the relevant findings in fundamental research could not be obtained without the accelerator-based methods of measurement and observation available at a synchrotron. If new technologies of a similar quality are going to be developed, I want Siemens Healthineers to be in on them early on and to seize the opportunity to industrialise those technologies.“

Head of Technology for Power and Vacuum Products at Siemens Healthineers

„As a leading company in the field of volume production of semiconductor components, we are very interested in being involved in technical innovations at an early stage and contributing our expertise. We look forward to a trust-based exchange with other industry players within the network. The technology platform thereby allows the competence and expertise for highly innovative solutions to be developed sustainably, which can enrich our corporate development in the long term.“

Senior Vice President (SVP) & Chief Operations Officer (COO) at Nexperia Germany GmbH